Company profile: EmergingMed
1.1 - Company Overview
Company description
- Provider of clinical trial enrollment optimization solutions, offering a Clinical Trial Navigation Service that helps patients find trials matching their diagnosis and treatment history using a national database of cancer treatment trials, and a comprehensive Trial Database covering all treatment trials from clinicaltrials.gov with additional updates from trial sponsors and sites.
Products and services
- EmergingMed Clinical Trial Navigation Service: EmergingMed delivers a patient-specific navigation service that matches diagnosis and treatment history to cancer treatment trials using a national database, enabling precise trial identification
- Trial Database: EmergingMed architects a national-scale trial database that includes all cancer treatment trials from clinicaltrials.gov, augmented with additional updates contributed by trial sponsors and individual sites
- Sponsor & Site Update Integration: EmergingMed constructs an update integration service that ingests additional trial updates from sponsors and sites to augment clinicaltrials.gov treatment trial records
- Data-integrated
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EmergingMed
Vyasa
HQ: United States
Website
- Description: Provider of an AI-powered platform for life sciences and healthcare organizations, enabling businesses to integrate and analyze data across cloud and on-premise sources into a unified data platform. Offers Certara.AI, a secure platform for deploying life science-specific GPTs with real-time indexing of organizational data for drug development, clinical trials, and regulatory submission.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vyasa company profile →
Genial Genetics
HQ: United Kingdom
Website
- Description: Provider of health care equipment and services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genial Genetics company profile →
Certara
HQ: United States
Website
- Description: Provider of biosimulation software and technology to accelerate medicines, including Phoenix WinNonlin for non-compartmental analysis, toxicokinetic and PK/PD modeling; Simcyp Simulator for physiologically based pharmacokinetic modeling; Pinnacle 21 for clinical data standardization and compliance; D360 for data access and integrated analysis; Certara Integral data repository; PK Submit for automating CDISC domains in NCA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Certara company profile →
Vesalius Therapeutics
HQ: United States
Website
- Description: Provider of the ContinuumDiscovery platform, which identifies clinical patterns in patient groups, links these patterns to gene circuits, and screens drug candidates to restore circuits to healthy functioning; focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vesalius Therapeutics company profile →
Proxeon
HQ: Denmark
Website
- Description: Provider of solutions addressing scientific and technical challenges in proteomics, leveraging multidisciplinary expertise across biology, physics, engineering and informatics, developed by scientists actively involved in proteomics research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proxeon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EmergingMed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EmergingMed
2.2 - Growth funds investing in similar companies to EmergingMed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EmergingMed
4.2 - Public trading comparable groups for EmergingMed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →